XXX - Lactobacillus delbrueckii bulgaricus + Streptococcus thermophilus & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Study overview

It is a double blind randomized clinical trial studying 500 million/day of Lactobacillus delbrueckii bulgaricus + Streptococcus thermophilus or placebo (starch) in 28 analyzed patients with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) during three months (1)

Outcome measures

Change in alanine amino transferase, aspartate aminotransferase, gammaglutamine transferase (1)

Results

In the probiotic group, there was a significant decrease in liver enzyme levels after treatment:

• Alanine Aminotransferase (ALT): Decreased from 67.7 ± 25.1…